Purdue Pharma Reaches $8B Opioid Deal With Justice Department Over OxyContin Sales

(By Brian Mann for NPR)

The Justice Department announced on Wednesday a global settlement of civil and criminal investigations into Purdue Pharma’s aggressive marketing of opioid medications, including OxyContin.

Federal officials have long maintained Purdue’s actions helped fuel a prescription opioid epidemic that has killed more than 232,000 Americans, according to the Centers for Disease Control and Prevention. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org

Leave a Reply